Last 24 quarters of trend data · Healthcare · Health Insurers
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 52.92 | — | 35.01 | 82.18 | — | 245.08 | 46.79 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | -25.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.31 | 0.31 | 0.96 | 0.76 | 0.98 | 0.92 | 0.72 | 0.97 | 0.77 | 0.82 | 0.55 | 0.37 | 0.87 | 0.71 | 0.58 | 0.66 | 1.48 | 1.50 | 1.41 | 1.45 | 2.10 |
| — | -65.9% | +32.7% | -21.8% | +27.3% | +12.3% | +31.9% | +160.8% | -11.6% | +14.8% | -5.3% | -43.8% | -41.3% | -52.4% | -59.0% | -54.4% | -29.4% | -38.2% | -57.8% | -54.2% | — | |
| P/B Ratio | 8.11 | 6.14 | 19.31 | 18.15 | 22.14 | 22.52 | 20.81 | 33.07 | 21.38 | 19.56 | 11.96 | 7.10 | 10.26 | 6.86 | 5.07 | 5.20 | 8.97 | 7.92 | 7.04 | 6.85 | 8.20 |
| — | -72.7% | -7.2% | -45.1% | +3.5% | +15.1% | +74.0% | +365.8% | +108.5% | +185.3% | +136.1% | +36.5% | +14.4% | -13.5% | -28.1% | -24.1% | +9.5% | -9.4% | -42.0% | -28.4% | — | |
| P/FCF | 18.21 | 11.03 | — | 7.74 | — | 5.67 | 34.71 | 107.75 | — | 33.44 | 31.64 | — | — | — | 9.34 | 3.74 | — | 5.47 | 114.93 | — | — |
| — | +94.6% | — | -92.8% | — | -83.1% | +9.7% | — | — | — | +238.6% | — | — | — | -91.9% | — | — | -94.6% | — | — | — | |
| EV / EBITDA | 16.91 | 75.49 | 23.80 | 36.16 | — | 53.58 | 23.44 | 390.36 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | +40.9% | +1.6% | -90.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | 86.17 | — | 28.25 | 54.50 | — | 109.28 | 30.59 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | -7.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 12.4% | 10.4% | 13.5% | 11.7% | 12.2% | 12.6% | 13.2% | 11.4% | 12.3% | 11.4% | 11.2% | 8.8% | 10.2% | 12.9% | 11.2% | 9.8% | 9.9% | 13.2% | 16.2% | 12.1% | 13.0% |
| — | -18.1% | +3.0% | +2.3% | -1.1% | +10.9% | +18.0% | +29.8% | +20.3% | -11.4% | -0.3% | -9.7% | +3.4% | -2.3% | -30.7% | -19.3% | -23.7% | -2.0% | +44.4% | +101.9% | +14.8% | |
| Operating Margin | 0.4% | -0.3% | 3.2% | 1.3% | -1.0% | 0.8% | 2.2% | -0.6% | -3.2% | -2.8% | -2.7% | -6.5% | -9.0% | -6.5% | -5.1% | -7.4% | -14.4% | -9.3% | -1.8% | -10.6% | -14.6% |
| — | -136.1% | +40.7% | +315.7% | +68.4% | +127.4% | +183.0% | +91.1% | +64.3% | +56.7% | +47.3% | +11.6% | +37.5% | +29.7% | -182.1% | +29.9% | +1.2% | +34.4% | +86.2% | +46.5% | -27.1% | |
| Net Margin | -0.0% | -0.6% | 2.7% | 0.9% | -1.1% | 0.4% | 1.5% | -1.0% | -4.4% | -3.8% | -3.5% | -7.4% | -10.1% | -7.7% | -6.2% | -8.5% | -15.8% | -11.2% | -3.2% | -11.8% | -16.0% |
| — | -258.0% | +77.4% | +194.0% | +75.5% | +109.8% | +143.8% | +86.7% | +56.3% | +50.3% | +42.8% | +12.8% | +35.6% | +31.3% | -94.9% | +28.1% | +1.8% | +28.5% | +78.2% | +44.5% | -21.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -0.5% | -3.0% | 15.5% | 5.9% | -6.5% | 2.5% | 12.5% | -8.7% | -28.7% | -22.0% | -18.7% | -32.1% | -27.2% | -17.5% | -13.1% | -16.1% | -22.3% | -14.2% | -3.9% | -13.6% | -15.2% |
| — | -220.6% | +23.6% | +168.1% | +77.5% | +111.2% | +167.0% | +72.9% | -5.7% | -25.6% | -42.8% | -99.3% | -21.8% | -23.0% | -231.8% | -18.2% | -47.0% | -3.3% | +69.4% | +53.9% | +85.5% | |
| ROA | -0.1% | -0.6% | 2.9% | 1.0% | -1.0% | 0.4% | 1.7% | -1.1% | -4.2% | -3.8% | -3.6% | -7.6% | -6.9% | -4.5% | -3.7% | -5.3% | -8.1% | -5.6% | -1.8% | -6.4% | -7.4% |
| — | -276.3% | +74.1% | +190.3% | +75.9% | +109.5% | +146.4% | +85.7% | +39.1% | +16.8% | +3.5% | -42.1% | +14.2% | +19.1% | -109.0% | +16.4% | -8.7% | +19.3% | +73.4% | +42.8% | +21.6% | |
| ROIC | — | — | — | — | — | — | 4779.0% | — | — | -2382.7% | -39.8% | -32.5% | -66.3% | — | — | -737.7% | — | — | -378.0% | — | — |
| — | — | — | — | — | — | +12110.7% | — | — | — | — | +95.6% | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.84 | 1.19 | 1.25 | 1.59 | 1.84 | 2.04 | 2.34 | 3.02 | 3.26 | 1.90 | 1.76 | 1.29 | 1.08 | 0.90 | 0.81 | 0.73 | 0.69 | 0.61 | 0.54 | 0.54 | 0.51 |
| — | -41.4% | -46.7% | -47.2% | -43.6% | +6.9% | +32.7% | +134.1% | +201.9% | +111.3% | +118.1% | +76.7% | +57.1% | +48.6% | +48.9% | +35.3% | +33.6% | +25.9% | +18.4% | +23.2% | -89.8% | |
| Debt / EBITDA | 7.29 | 76.53 | 6.62 | 14.12 | — | 21.04 | 11.07 | 147.49 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | +263.7% | -40.2% | -90.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.71 | 1.71 | 1.70 | 1.58 | 1.71 | 1.61 | 1.66 | 1.69 | 1.88 | 1.60 | 1.61 | 1.57 | 1.84 | 1.63 | 1.70 | 1.79 | 2.37 | 2.03 | 2.74 | 2.90 | 3.31 |
| — | +6.1% | +2.2% | -6.7% | -9.1% | +0.7% | +3.1% | +7.6% | +2.3% | -1.5% | -5.2% | -12.2% | -22.4% | -20.1% | -37.9% | -38.3% | -28.4% | -38.3% | -19.7% | -18.5% | +91.7% | |
| Quick Ratio | 1.71 | 1.71 | 1.70 | 1.58 | 1.71 | 1.61 | 1.66 | 1.69 | 1.88 | 1.60 | 1.61 | 1.57 | 1.84 | 1.63 | 1.70 | 1.79 | 2.37 | 2.03 | 2.74 | 2.90 | 3.31 |
| — | +6.1% | +2.2% | -6.7% | -9.1% | +0.7% | +3.1% | +7.6% | +2.3% | -1.5% | -5.2% | -12.2% | -22.4% | -20.1% | -37.9% | -38.3% | -28.4% | -38.3% | -19.7% | -18.5% | +91.7% | |
| Interest Coverage | 0.94 | -0.89 | 9.85 | 3.82 | -2.60 | 1.94 | 5.78 | -1.36 | -4.65 | -2.81 | -3.21 | -7.58 | -7.62 | -5.42 | -4.41 | -6.45 | -10.86 | -7.70 | -1.58 | -8.27 | -9.74 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 24 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ALHC stock.
Alignment Healthcare, Inc.'s current P/E is 52.9x. The average P/E over the last 2 quarters is 58.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Alignment Healthcare, Inc.'s current operating margin is 0.4%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Alignment Healthcare, Inc.'s business trajectory between earnings reports.